Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Aug 9;13(Suppl 1):28.
doi: 10.1186/s40248-018-0138-3. eCollection 2018.

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference

Stefano Aliberti  1 , James D Chalmers  2
Affiliations
Editorial

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference

Stefano Aliberti et al. Multidiscip Respir Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Not applicable.Not applicable.Speakers/ Advisory boards on bronchiectasis in the past two years for Bayer; Insmed; Chiesi, Menarini, Mundipharma, Glaxosmithkline, Astrazeneca, Grifols, Guidotti, Malesci, Zambon, Actavis, Novartis, Bi, Raptor, Horizon Pharma. In addition. SA and CJD are Guest Editor of the Supplement on Bronchiectasis, whereas SA is Associate editor of Multidisciplinary Respiratory Medicine.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J. 2015;45(5):1446–1462. doi: 10.1183/09031936.00119114. - DOI - PubMed
    1. McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4(12):969–979. doi: 10.1016/S2213-2600(16)30320-4. - DOI - PMC - PubMed
    1. Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186–193. doi: 10.1183/13993003.01033-2015. - DOI - PMC - PubMed
    1. Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843–849. doi: 10.1183/09031936.00003709. - DOI - PubMed
    1. Aliberti S, Hill AT, Mantero M, Battaglia S, Centanni S, Lo Cicero S, Lacedonia D, Saetta M, Chalmers JD, Blasi F, SIP Bronchiectasis Audit Working Group Quality standards for the management of bronchiectasis in Italy: a national audit. Eur Respir J. 2016;48(1):244–248. doi: 10.1183/13993003.00232-2016. - DOI - PubMed

Publication types